These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 30201031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany.
    Hampel V, Knaus M, Schäfer J, Beugnet F, Rehbein S.
    Parasite; 2018; 25():63. PubMed ID: 30516132
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
    Snyder DE, Wiseman S, Liebenberg JE.
    Parasit Vectors; 2017 Nov 01; 10(1):532. PubMed ID: 29089049
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
    Fankhauser R, Hamel D, Dorr P, Reinemeyer CR, Crafford D, Bowman DD, Ulrich M, Yoon S, Larsen DL.
    Vet Parasitol; 2016 Jul 30; 225():117-22. PubMed ID: 27369586
    [Abstract] [Full Text] [Related]

  • 12. Afoxolaner and fluralaner treatment do not impact on cutaneous Demodex populations of healthy dogs.
    Zewe CM, Altet L, Lam ATH, Ferrer L.
    Vet Dermatol; 2017 Oct 30; 28(5):468-e107. PubMed ID: 28544307
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
    Paterson TE, Halliwell RE, Fields PJ, Louw ML, Ball G, Louw J, Pinckney R.
    Vet Parasitol; 2014 Oct 15; 205(3-4):687-96. PubMed ID: 25262617
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of afoxolaner for the treatment of ear mite infestation under field conditions.
    Panarese R, Iatta R, Lia RP, Lebon W, Beugnet F, Otranto D.
    Vet Parasitol; 2021 Dec 15; 300():109607. PubMed ID: 34735846
    [Abstract] [Full Text] [Related]

  • 18. Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs.
    Lebon W, Tielemans E, Rehbein S, Dumont P, Yoon S, Beugnet F, Jeannin P, Larsen D, Halos L.
    Parasit Vectors; 2016 Sep 02; 9(1):485. PubMed ID: 27589951
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.
    Six RH, Becskei C, Mazaleski MM, Fourie JJ, Mahabir SP, Myers MR, Slootmans N.
    Vet Parasitol; 2016 May 30; 222():62-6. PubMed ID: 26971196
    [Abstract] [Full Text] [Related]

  • 20. Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs.
    Carithers D, Crawford J, de Vos C, Lotriet A, Fourie J.
    Parasit Vectors; 2016 Dec 09; 9(1):635. PubMed ID: 27938395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.